tiprankstipranks
Universal Health Services (UHS)
NYSE:UHS
US Market

Universal Health (UHS) Stock Forecast & Price Target

567 Followers
See the Price Targets and Ratings of:

UHS Analyst Ratings

Moderate Buy
9Ratings
Moderate Buy
4 Buy
4 Hold
1 Sell
Based on 9 analysts giving stock ratings to
Universal
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

UHS Stock 12 Month Forecast

Average Price Target

$246.00
▲(39.22% Upside)
Based on 9 Wall Street analysts offering 12 month price targets for Universal Health in the last 3 months. The average price target is $246.00 with a high forecast of $320.00 and a low forecast of $212.00. The average price target represents a 39.22% change from the last price of $176.70.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"161":"$161","201":"$201","241":"$241","281":"$281","321":"$321"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":320,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$320.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":246,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$246.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":212,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$212.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[161,201,241,281,321],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,177.94,188.8676923076923,199.79538461538462,210.72307692307692,221.65076923076924,232.57846153846154,243.50615384615384,254.43384615384616,265.36153846153843,276.28923076923076,287.2169230769231,298.14461538461535,309.0723076923077,{"y":320,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,177.94,183.17538461538462,188.41076923076923,193.64615384615385,198.88153846153847,204.1169230769231,209.3523076923077,214.5876923076923,219.82307692307694,225.05846153846153,230.29384615384618,235.52923076923076,240.76461538461538,{"y":246,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,177.94,180.56,183.18,185.8,188.42,191.04,193.66,196.28,198.9,201.52,204.14,206.76,209.38,{"y":212,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":187.07,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":173.942,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":186.838,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":188.393,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":162.508,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":181.055,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":203.145,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":216.621,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":239.197,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":217.808,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":201.664,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":206.42,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":177.94,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$320.00Average Price Target$246.00Lowest Price Target$212.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on UHS
J.P. Morgan
J.P. Morgan
$235
Hold
32.99%
Upside
Reiterated
03/17/26
Analysts Conflicted on These Healthcare Names: Cochlear (Other OTC: CHEOF), Universal Health (NYSE: UHS) and Vera Therapeutics (NASDAQ: VERA)
UBS
$320
Buy
81.10%
Upside
Reiterated
03/12/26
Analysts' Top Healthcare Picks: Solid Biosciences (SLDB), Universal Health (UHS)
RBC Capital Analyst forecast on UHS
RBC Capital
RBC Capital
$245$216
Hold
22.24%
Upside
Reiterated
03/09/26
RBC Capital Keeps Their Hold Rating on Universal Health (UHS)
Wells Fargo Analyst forecast on UHS
Wells Fargo
Wells Fargo
$235$212
Hold
19.98%
Upside
Reiterated
03/02/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Vaxcyte (NASDAQ: PCVX), Universal Health (NYSE: UHS) and MoonLake Immunotherapeutics (NASDAQ: MLTX)
TD Cowen
$245
Buy
38.65%
Upside
Reiterated
02/27/26
Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (NASDAQ: TNDM), PACS Group Inc (NYSE: PACS) and Universal Health (NYSE: UHS)
Bank of America Securities Analyst forecast on UHS
Bank of America Securities
Bank of America Securities
$215
Sell
21.68%
Upside
Reiterated
02/26/26
Sell Rating on Universal Health: Weaker Underlying Demand, Policy Risks, and Overvalued Shares Support Underperform Stance
Cantor Fitzgerald Analyst forecast on UHS
Cantor Fitzgerald
Cantor Fitzgerald
$250$229
Hold
29.60%
Upside
Reiterated
02/26/26
Cantor Fitzgerald Sticks to Their Hold Rating for Universal Health (UHS)
Barclays
$262$268
Buy
51.67%
Upside
Reiterated
02/25/26
Barclays Keeps Their Buy Rating on Universal Health (UHS)
Guggenheim Analyst forecast on UHS
Guggenheim
Guggenheim
$274
Buy
55.07%
Upside
Reiterated
02/23/26
Guggenheim Keeps Their Buy Rating on Universal Health (UHS)
Raymond James Analyst forecast on UHS
Raymond James
Raymond James
$270
Buy
52.80%
Upside
Upgraded
11/03/25
Universal Health upgraded to Outperform from Market Perform at Raymond JamesUniversal Health upgraded to Outperform from Market Perform at Raymond James
Mizuho Securities Analyst forecast on UHS
Mizuho Securities
Mizuho Securities
$242$267
Buy
51.10%
Upside
Reiterated
11/03/25
Universal Health price target raised to $267 from $242 at MizuhoUniversal Health price target raised to $267 from $242 at Mizuho
Morgan Stanley Analyst forecast on UHS
Morgan Stanley
Morgan Stanley
$200$233
Hold
31.86%
Upside
Reiterated
10/29/25
Universal Health's Mixed Q3 Performance and Stable Outlook Justify Hold Rating
KeyBanc
Hold
Reiterated
10/28/25
KeyBanc Remains a Hold on Universal Health (UHS)
Leerink Partners Analyst forecast on UHS
Leerink Partners
Leerink Partners
$276
Buy
56.20%
Upside
Reiterated
10/22/25
Leerink Partners Keeps Their Buy Rating on Universal Health (UHS)
Goldman Sachs Analyst forecast on UHS
Goldman Sachs
Goldman Sachs
$180$219
Hold
23.94%
Upside
Reiterated
10/15/25
Goldman Sachs Sticks to Their Hold Rating for Universal Health (UHS)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on UHS
J.P. Morgan
J.P. Morgan
$235
Hold
32.99%
Upside
Reiterated
03/17/26
Analysts Conflicted on These Healthcare Names: Cochlear (Other OTC: CHEOF), Universal Health (NYSE: UHS) and Vera Therapeutics (NASDAQ: VERA)
UBS
$320
Buy
81.10%
Upside
Reiterated
03/12/26
Analysts' Top Healthcare Picks: Solid Biosciences (SLDB), Universal Health (UHS)
RBC Capital Analyst forecast on UHS
RBC Capital
RBC Capital
$245$216
Hold
22.24%
Upside
Reiterated
03/09/26
RBC Capital Keeps Their Hold Rating on Universal Health (UHS)
Wells Fargo Analyst forecast on UHS
Wells Fargo
Wells Fargo
$235$212
Hold
19.98%
Upside
Reiterated
03/02/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Vaxcyte (NASDAQ: PCVX), Universal Health (NYSE: UHS) and MoonLake Immunotherapeutics (NASDAQ: MLTX)
TD Cowen
$245
Buy
38.65%
Upside
Reiterated
02/27/26
Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (NASDAQ: TNDM), PACS Group Inc (NYSE: PACS) and Universal Health (NYSE: UHS)
Bank of America Securities Analyst forecast on UHS
Bank of America Securities
Bank of America Securities
$215
Sell
21.68%
Upside
Reiterated
02/26/26
Sell Rating on Universal Health: Weaker Underlying Demand, Policy Risks, and Overvalued Shares Support Underperform Stance
Cantor Fitzgerald Analyst forecast on UHS
Cantor Fitzgerald
Cantor Fitzgerald
$250$229
Hold
29.60%
Upside
Reiterated
02/26/26
Cantor Fitzgerald Sticks to Their Hold Rating for Universal Health (UHS)
Barclays
$262$268
Buy
51.67%
Upside
Reiterated
02/25/26
Barclays Keeps Their Buy Rating on Universal Health (UHS)
Guggenheim Analyst forecast on UHS
Guggenheim
Guggenheim
$274
Buy
55.07%
Upside
Reiterated
02/23/26
Guggenheim Keeps Their Buy Rating on Universal Health (UHS)
Raymond James Analyst forecast on UHS
Raymond James
Raymond James
$270
Buy
52.80%
Upside
Upgraded
11/03/25
Universal Health upgraded to Outperform from Market Perform at Raymond JamesUniversal Health upgraded to Outperform from Market Perform at Raymond James
Mizuho Securities Analyst forecast on UHS
Mizuho Securities
Mizuho Securities
$242$267
Buy
51.10%
Upside
Reiterated
11/03/25
Universal Health price target raised to $267 from $242 at MizuhoUniversal Health price target raised to $267 from $242 at Mizuho
Morgan Stanley Analyst forecast on UHS
Morgan Stanley
Morgan Stanley
$200$233
Hold
31.86%
Upside
Reiterated
10/29/25
Universal Health's Mixed Q3 Performance and Stable Outlook Justify Hold Rating
KeyBanc
Hold
Reiterated
10/28/25
KeyBanc Remains a Hold on Universal Health (UHS)
Leerink Partners Analyst forecast on UHS
Leerink Partners
Leerink Partners
$276
Buy
56.20%
Upside
Reiterated
10/22/25
Leerink Partners Keeps Their Buy Rating on Universal Health (UHS)
Goldman Sachs Analyst forecast on UHS
Goldman Sachs
Goldman Sachs
$180$219
Hold
23.94%
Upside
Reiterated
10/15/25
Goldman Sachs Sticks to Their Hold Rating for Universal Health (UHS)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Universal Health

3 Months
xxx
Success Rate
21/31 ratings generated profit
68%
Average Return
+4.51%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 67.74% of your transactions generating a profit, with an average return of +4.51% per trade.
1 Year
Kevin FischbeckBank of America Securities
Success Rate
14/19 ratings generated profit
74%
Average Return
+12.12%
reiterated a sell rating last month
Copying Kevin Fischbeck's trades and holding each position for 1 Year would result in 73.68% of your transactions generating a profit, with an average return of +12.12% per trade.
2 Years
xxx
Success Rate
24/31 ratings generated profit
77%
Average Return
+11.61%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 77.42% of your transactions generating a profit, with an average return of +11.61% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

UHS Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
0
0
1
2
2
Buy
41
23
39
33
30
Hold
12
6
7
12
11
Sell
1
0
1
1
1
Strong Sell
0
0
0
0
0
total
54
29
48
48
44
In the current month, UHS has received 32 Buy Ratings, 11 Hold Ratings, and 1 Sell Ratings. UHS average Analyst price target in the past 3 months is 246.00.
Each month's total comprises the sum of three months' worth of ratings.

UHS Financial Forecast

UHS Earnings Forecast

Next quarter’s earnings estimate for UHS is $5.41 with a range of $4.76 to $6.61. The previous quarter’s EPS was $5.88. UHS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year UHS has Performed in-line its overall industry.
Next quarter’s earnings estimate for UHS is $5.41 with a range of $4.76 to $6.61. The previous quarter’s EPS was $5.88. UHS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year UHS has Performed in-line its overall industry.

UHS Sales Forecast

Next quarter’s sales forecast for UHS is $4.39B with a range of $4.24B to $4.48B. The previous quarter’s sales results were $4.49B. UHS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year UHS has Performed in-line its overall industry.
Next quarter’s sales forecast for UHS is $4.39B with a range of $4.24B to $4.48B. The previous quarter’s sales results were $4.49B. UHS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year UHS has Performed in-line its overall industry.

UHS Stock Forecast FAQ

What is UHS’s average 12-month price target, according to analysts?
Based on analyst ratings, Universal Health Services’s 12-month average price target is 246.00.
    What is UHS’s upside potential, based on the analysts’ average price target?
    Universal Health Services has 39.22% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is UHS a Buy, Sell or Hold?
          Universal Health Services has a consensus rating of Moderate Buy which is based on 4 buy ratings, 4 hold ratings and 1 sell ratings.
            What is Universal Health Services’s price target?
            The average price target for Universal Health Services is 246.00. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $320.00 ,the lowest forecast is $212.00. The average price target represents 39.22% Increase from the current price of $176.7.
              What do analysts say about Universal Health Services?
              Universal Health Services’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Streets Analysts.
                How can I buy shares of UHS?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.